ARTICLE | Clinical News
INFINITI CYP2C19 Assay regulatory update
November 1, 2010 7:00 AM UTC
FDA granted 510(k) clearance for AutoGenomics' INFINITI CYP2C19 Assay as an aid to clinicians in determining a therapeutic strategy for drugs that are metabolized by the CYP450 2C19 gene. The in vitro...